Bayer to fight 'resolutely' US claims against Cipro patent
Bayer AG said it will "resolutely" fight several legal claims that have emerged in the US against the validity of its patent on anti-anthrax drug Cipro.
In a statement, Bayer said that its patent on Cipro "is not in question" until it runs out in 2003.